Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2-breast cancer

被引:0
|
作者
Elias, Anthony D.
Staley, Alyse
Fornier, Monica
Vidal, Gregory A.
Sams, Sharon
Spoelstra, Nicole
Kabos, Peter
Diamond, Jennifer R.
Shagisultanova, Elena
Gallagher, Rosa I.
Wulfkuhle, Julia
Petricoin, Emanuel
Zolman, Kathryn
Biller, Stephanie
Alami, Vida
McSpadden, Tessa
Borges, Virginia
Crump, Lyndsey S.
Gao, Dexiang
Richer, Jennifer K.
机构
关键词
D O I
10.1158/1538-7445.AM2023-CT144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT144
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2-primary breast cancer (BC)
    Elias, Anthony D.
    Fournier, Monica
    Vidal, Gregory A.
    Sams, Sharon
    Spoelsta, Nicole
    Kabos, Peter
    Diamond, Jennifer R.
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    Wulfkuhle, Julia
    Petricoin, Emanuel
    Carter, Lisa
    Zolman, Kathryn
    Armstead, Stephanie
    Winchester, Alyse
    McSpadden, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Richer, Jennifer
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [2] Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer
    Elias, Anthony D.
    Spoelstra, Nicole S.
    Staley, Alyse W.
    Sams, Sharon
    Crump, Lyndsey S.
    Vidal, Gregory A.
    Borges, Virginia F.
    Kabos, Peter
    Diamond, Jennifer R.
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadden, Tessa
    Crawford, Gloria
    D'Alessandro, Angelo
    Zolman, Kathryn L.
    van Bokhoven, Adrie
    Zhuang, Yonghua
    Gallagher, Rosa I.
    Wulfkuhle, Julia D.
    Petricoin III, Emanuel F.
    Gao, Dexiang
    Richer, Jennifer K.
    [J]. NPJ BREAST CANCER, 2023, 9 (01)
  • [3] Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer
    Anthony D. Elias
    Nicole S. Spoelstra
    Alyse W. Staley
    Sharon Sams
    Lyndsey S. Crump
    Gregory A. Vidal
    Virginia F. Borges
    Peter Kabos
    Jennifer R. Diamond
    Elena Shagisultanova
    Anosheh Afghahi
    Jose Mayordomo
    Tessa McSpadden
    Gloria Crawford
    Angelo D’Alessandro
    Kathryn L. Zolman
    Adrie van Bokhoven
    Yonghua Zhuang
    Rosa I. Gallagher
    Julia D. Wulfkuhle
    Emanuel F. Petricoin III
    Dexiang Gao
    Jennifer K. Richer
    [J]. npj Breast Cancer, 9
  • [4] Phase II trial of fulvestrant plus enzalutamide in ER+/Her2-advanced breast cancer
    Elias, Anthony D.
    Spoelsta, Nicole
    Vidal, Gregory A.
    Sams, Sharon
    Kabos, Peter
    Diamond, Jennifer R.
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadden, Tessa
    Crawford, Gloria
    Carter, Lisa
    Zolman, Kathryn
    Armstead, Stephanie
    Winchester, Alyse
    Borges, Virginia
    Wulfkuhle, Julia
    Petricoin, Emanuel
    Gao, Dexiang
    Richer, Jennifer
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [5] Response of persistent metastatic ER+/Her2-breast cancer treated with fulvestrant plus enzalutamide
    Richer, Jennifer
    Spoelstra, Nicole
    Winchester, Alyse
    Wulfkuhlue, Julia
    Gallagher, Rosa
    Sams, Sharon
    Vidal, Gregory
    Kabos, Peter
    Diamond, Jennifer
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadded, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Petricoin, Emanuel
    Elias, Anthony
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [6] Laboratory analyses of metastatic ER+/Her2-breast cancer treated with fulvestrant plus enzalutamide.
    Richer, Jennifer K.
    Spoelstra, Nicole S.
    Winchester, Alyse
    Wulfkuhle, Julia
    Sams, Sharon B.
    Vidal, Gregory
    Kabos, Peter
    Diamond, Jennifer
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadden, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Petricoin, Emanuel
    Elias, Anthony D.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [7] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [8] Estetrol for treatment of advanced ER+/HER2-breast cancer
    Schmidt, Marcus
    Hoenig, Arnd
    Zimmerman, Yvette
    Verhoeven, Carole
    Almstedt, Katrin
    Battista, Marco
    Lenhard, Hans Georg
    Krijgh, Jan
    Bennink, Herjan Coelingh
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [9] Dysregulated expression of repetitive DNA in ER+/HER2-breast cancer
    Yandim, Cihangir
    Karakulah, Gokhan
    [J]. CANCER GENETICS, 2019, 239 : 36 - 45
  • [10] Tumor infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Esposito, A.
    Viale, G.
    Curigliano, G.
    [J]. CANCER RESEARCH, 2019, 79 (04)